Benjamin S. Bleier, M.D., Named Recipient of 2014 Norman Knight Leadership Development Award in Otolaryngology
CONTACT: Joe O’Shea
BOSTON (August 27, 2014) – Benjamin S. Bleier, M.D., an ear, nose and throat physician at Massachusetts Eye and Ear, has been named the 2014 recipient of the Norman Knight Leadership Development Award for Otolaryngology. The Norman Knight Leadership Development Awards recognize future leaders in otolaryngology and ophthalmology, providing financial support for young clinicians during a critical juncture in their careers.
An assistant professor of Otology and Laryngology at Harvard Medical School (HMS), Dr. Bleier specializes in rhinology, which is the study of the nose (including the sinuses), and endoscopic skull base surgery, a minimally invasive procedure in which instruments are inserted through the natural openings in the skull (nose, mouth).
Dr. Bleier was selected for exceptional promise by Chief of Otolaryngology D. Bradley Welling, M.D., Ph.D., FACS, who also serves as Chair, Otology and Laryngology, at HMS. “Dr. Bleier is a highly motivated and focused individual whose clinical activities in resolving paranasal sinus disorders and anterior skull-base lesions have led him to form innovative research questions driven by a desire to improve his patients’ lives,” says Dr. Welling.
“Through his research efforts, Dr. Bleier is advancing endoscopic surgical techniques, especially in finding ways to deliver drugs to the brain using novel graft techniques in the nose,” adds Dr. Welling. “This innovative work could lead to new drug delivery methods to the central nervous system to treat symptoms of conditions such as Parkinson’s disease.”
Dr. Bleier has developed a strong reputation as a clinical expert in using endoscopic skull base surgery to manage sinus, orbit, and cranial base lesions, including tumors, cerebrospinal fluid (CSF) leaks, and encephaloceles. He has traveled the world to discuss his innovative techniques in anterior skull base and complex paranasal sinus surgery, and his related translational research efforts.
In 2013, Dr. Bleier was appointed associate editor of the American Journal of Rhinology and Allergy. He has published more than 40 peer-reviewed journal articles to date.
A graduate of the University of Pennsylvania’s Perelman School of Medicine, Dr. Bleier has also been recognized by the Michael J. Fox Foundation, Boston Magazine, Harvard Medicine Magazine, and The Scientist Magazine for his pioneering work in using the nasal lining to deliver drugs to the brain.
“As a resident at the University of Pennsylvania Medical Center, I became intrigued by the field of rhinology,” says Dr. Bleier. “Rhinology is a relatively young discipline, only about 25 years old, and we're in the very early stages of understanding the diseases of the nose and sinuses.
“For example, we know very little about the mechanisms of Sinusitis – what causes the inflammation? – so it’s an exciting field to specialize in,” adds Dr. Bleier. “What appeals to me most is that there's so much room for innovation on both the research and clinical sides of the discipline.”